PV Bulletin

CAROTONE skin-brightening products found to contain undeclared prescription-only medicine

The TGA is advising consumers that CAROTONE products marketed for skin brightening may pose a serious risk to health.

Primary source: Safety monitoring and information

PV Impact Brief

Urgency: HighConfidence: high

What changed

A safety alert has been issued regarding CAROTONE skin-brightening products, highlighting the presence of undeclared prescription-only medicines.

Why it matters

This alert is crucial as it addresses potential health risks associated with the use of non-compliant skin-brightening products, emphasizing consumer safety.

Action needed

Health professionals and stakeholders should review the safety signals linked to CAROTONE products in their signal management processes.

Relevant for
Medical Safety Lead
Processes impacted
Signal Management
Owner

Regulatory Intelligence Lead

Review cadence

Review in the next regulatory intelligence cycle.

Evidence and confidence

Confidence: highSource updated: Aug 25, 2026

Full briefing

Practical implication

Health professionals and stakeholders should review the safety signals linked to CAROTONE products in their signal management processes.

The TGA has issued an alert regarding CAROTONE skin-brightening products that contain undeclared prescription-only medicine, indicating a potential serious health risk for consumers.

What changed: A safety alert has been issued regarding CAROTONE skin-brightening products, highlighting the presence of undeclared prescription-only medicines.

Why it matters: This alert is crucial as it addresses potential health risks associated with the use of non-compliant skin-brightening products, emphasizing consumer safety.

Practical implication: Health professionals and stakeholders should review the safety signals linked to CAROTONE products in their signal management processes.

View original source

  • Source: TGA Safety Alerts - Safety information
  • Published at source: 2026-08-25T12:00:00.000Z
  • Discovered by monitor: 2026-08-25T15:26:15.851Z

Published from the regulator source ingestion pipeline after PV impact triage.

Related updates for your role

publicFDA · USA · Updated Sep 4, 2026

FDA Grants Accelerated Approval to Etcamah for Advanced Breast Cancer

Urgency: High

Regulatory teams must prepare for updating labeling to include details on the new indication and required diagnostic methods, along with planning for the confirmatory studies mandated by the FDA.

Signal ManagementLabelingRegulatory Intelligence Lead
SOP Impact2 SOPs
ConfidenceHigh
Relevant for: Regulatory Intelligence Lead
verifiedRegulatory action: Regulators
Read impact briefarrow_forward
publicUK Health Security Agency · UK · Updated Sep 7, 2026

Low Flu Vaccination Rates Among Primary School Children

Urgency: High

Parents are reminded to complete and return flu vaccination consent forms promptly as vaccination sessions in schools are set to start this week, aiming for completion by late November.

Signal ManagementPV Quality Lead
SOP Impact1 SOPs
ConfidenceHigh
Relevant for: PV Quality Lead, Medical Safety Lead
verifiedRegulatory action: Regulators
Read impact briefarrow_forward
publicANSM (France) · France · Updated Sep 7, 2026Translated From French

Recall of Gore Viabahn Endoprosthesis with Bioactive Heparin Coating

Urgency: High

Health establishments receiving affected devices must be notified, and protocols established to ensure compliance with the recall.

Signal ManagementQPPV
SOP Impact1 SOPs
ConfidenceHigh
Relevant for: QPPV, Medical Safety Lead
verifiedRegulatory action: Regulators
Read impact briefarrow_forward
publicANSM (France) · France · Updated Sep 7, 2026Translated From French

Atellica CH Revised C-Reactive Protein (RCRP) Safety Information - Siemens Healthcare Diagnostics

Urgency: High

Laboratories must implement the safety measures as indicated by the action registration number R2625739, effective from the notice date of September 7, 2026.

Signal ManagementQPPV
SOP Impact1 SOPs
ConfidenceHigh
Relevant for: QPPV, Medical Safety Lead
verifiedRegulatory action: Regulators
Read impact briefarrow_forward